SIMMARON RESEARCH INC
Data sourced from IRS 990 public filings
SIMMARON RESEARCH INC TO CONDUCT RESEARCH ON THE ETIOLOGY, PATHOGENESIS, BIOMARKERS, AND TREATMENT OF MYALGIC ENCEPHELOMYELITIS (ME) FORMERLY KNOW AS CHRONIC FATIGUE SYNDROME (CFS). OUR MISSION STATEMENT IS TO SCIENTIFICALLY REDEFINE ME/CFS.
SIMMARON RESEARCH INC has received 9 grants from 5 known foundation funders. Revenue increased from $626,336 in 2023 to $816,332 in 2024. Most recent reported revenue: $816,332.
Annual Revenue
$816,332
Known Funders
5
Grants Received
9
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $816,332 | $865,024 | $250,895 |
| 2023 | $626,336 | $677,554 | $121,145 |
| 2022 | $297,373 | $313,124 | $250,197 |
| 2021 | $483,746 | $474,224 | $221,950 |
| 2020 | $668,052 | $688,146 | $198,477 |
| 2019 | $341,819 | $729,019 | $173,782 |
| 2018 | $481,688 | $506,363 | $552,671 |
| 2017 | $540,107 | $425,205 | $593,558 |
Top Funders
SARASOTA, FL
SARASOTA, FL
LOS ANGELES, CA
LOS ANGELES, CA
LAS VEGAS, NV
LAS VEGAS, NV
WASHINGTON, DC
LAS VEGAS, NV
SEATTLE, WA
Key Personnel
From 2024 IRS 990 filing
WES BROWN
DIRECTOR
GUNNAR GOTTSCHALK
DIRECTOR
JAN ARMSTRONG
DIRECTOR CHAIRMAN
COURTNEY ALEXANDER
DIRECTOR PRESIDENT
Frequently Asked Questions
Other Nonprofits in Nevada
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.